Characteristics of binding to estrogen, androgen, progestin, and glucocorticoid receptors in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and their hormonal control.

Abstract In order to perform simultaneous measurement of binding of four classes of steroids and facilitate study of their mechanism of action in 7,12-dimethylbenz( a )anthracene-induced mammary tumors in the rat, we have investigated in detail the binding characteristics of 17β-[2,4,6,7,16,17- 3 H]estradiol (17β-[ 3 H]estradiol), 17,21-[6,7- 3 H]dimethyl-19-norpregna-4,9-diene-3,20-dione ([ 3 H]R5020), [ 3 H]dexamethasone (DEX), and 5α-[ 3 H]dihydrotestosterone (DHT) in cytosol prepared from these tumors. Following assessment of optimal buffer composition, separation of bound and free steroids was achieved with dextran-coated charcoal, protamine sulfate, or hydroxylapatite. Using the same buffer and the optimal method of separation for each tracer, we have found that the time course of binding of each labeled steroid was fast, the slowest rate of association being obtained with [ 3 H]DEX ( t ⋍ 100 to 150 min) at 4°. In addition, the level of specific binding of each tracer was stable for a period of at least 21 hr at 4° but decreased markedly at 23° (except with 17β-[ 3 H]estradiol). Complete exchange of the tracer from the binding component was achieved at 4° for [ 3 H]R5020 and at 23° for 17β-[ 3 H]estradiol. Although [ 3 H]DEX dissociated from its binding component at 4°, the receptor complex was unstable during long-term incubations necessary to achieve complete exchange. No significant exchange of [ 3 H]DHT binding occurred at 4°. Using six increasing concentrations of a large series of unlabeled steroids, each tracer showed a high degree of binding specificity. Sucrose gradient analysis performed in low-ionic-strength buffer revealed specific and protamine sulfate-precipitable steroid-binding components migrating in the 8 to 9S area for 17β-[ 3 H]estradiol, 7S and 4 to 5S for [ 3 H]R5020, and 7 to 8S for [ 3 H]DEX and [ 3 H]DHT. Sucrose gradient analysis in a high-ionic-strength buffer (0.4 m KCl) gave only one labeled area (3 to 5S) for each tracer. Scatchard analysis revealed K d 9s of 0.14 nm for 17β-[ 3 H]estradiol, 2.9 nm for [ 3 H]R5020, 13 nm for [ 3 H]DEX, and 0.45 nm for [ 3 H]DHT binding. In a second series of experiments, while adrenalectomy had no effect on the binding of any of the four classes of steroids, 17β-[ 3 H]estradiol, [ 3 H]R5020, and [ 3 H]DHT binding levels were decreased in 7,12-dimethylbenz( a )anthracene-induced mammary tumors after ovariectomy plus adrenalectomy or hypophysectomy, while the binding of [ 3 H]DEX remained unchanged. The present data describe the optimal conditions for simultaneous and specific measurement of binding of four classes of steroids in cytosol from 7,12-dimethylbenz( a )anthracene-induced mammary tumors in the rat. Moreover, as revealed by hypophysectomy, adrenalectomy, and ovariectomy, the levels of the progesterone and glucocorticoid receptors are under different hormonal control.

[1]  F. Labrie,et al.  Specific binding of [3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH). , 1979, Journal of steroid biochemistry.

[2]  F. Labrie,et al.  Effects of estradiol and prolactin on steroid receptor levels in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and uterus in the rat. , 1978, Journal of steroid biochemistry.

[3]  U. Kim,et al.  Characterization of androgen receptors in 7,12-dimethylbenz(a)-anthracene-induced and transplantable rat mammary tumors. , 1978, Cancer research.

[4]  J. Asselin,et al.  Characteristics of androgen binding in rat adrenal tissue using [su3]H]methyltrienolone (R1881) as tracer , 1977, Steroids.

[5]  M. Caron,et al.  Control of hormone receptor levels and growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors by estrogens, progesterone and prolactin. , 1977, Endocrinology.

[6]  D. Medina,et al.  Estrogen receptor characterization in a transplantable mouse mammary tumor. , 1977, Cancer research.

[7]  H. Friesen,et al.  Hormone binding by human mammary carcinoma. , 1977, Cancer research.

[8]  W. McGuire,et al.  Progesterone and Progesterone Receptors in Experimental Breast Cancer 1 , 2006 .

[9]  D. Chan,et al.  The binding of a synthetic progestin, R5020 to transcortin and serum albumin. , 1977, The Journal of clinical endocrinology and metabolism.

[10]  F. Rosen,et al.  Evidence for a factor in liver cytosol which controls the competition between progesterone and triamcinolone acetonide for the glucocorticoid receptor. , 1977, Life sciences.

[11]  P. Ballard,et al.  The role of sulfhydryl groups in the binding of glucocorticoids by cytoplasmic receptors of lung and other mammalian tissues. , 1977, Endocrinology.

[12]  H. Rochefort,et al.  Estradiol dependent decrease of binding inhibition by anti-estrogens (a possible test of receptor activation). , 1977, Biochemical and biophysical research communications.

[13]  E. Milgrom,et al.  Characterization and assay of progesterone receptor in human mammary carcinoma. , 1977, Cancer research.

[14]  F. Labrie,et al.  Binding of [3H] methyltrienolone (R 1881) in rat prostate and human benign prostatic hypertrophy (BPH) , 1976, Steroids.

[15]  J. Funder,et al.  Glucocorticoid receptors: evidence for a second, non-glucocorticoid binding site. , 1976, Endocrinology.

[16]  J. Wittliff,et al.  Characteristics of progesterone-binding components in neoplastic mammary tissues of the rat. , 1976, Cancer research.

[17]  P. Coulson,et al.  Hydroxylapatite "batch" assay for estrogen receptors: increased sensitivity over present receptor assays. , 1976, Journal of steroid biochemistry.

[18]  C. Bonne,et al.  Assay of androgen binding sites by exchange with methyltrienolone (R 1881) , 1976, Steroids.

[19]  H. Rochefort,et al.  Regulation of estrogen receptors in ovarian-dependent rat mammary tumors. I. Effects of castration and prolactin. , 1976, Endocrinology.

[20]  P. Kelly,et al.  Specific progesterone receptors in dimethylbenzanthracene (DMBA)-induced mammary tumors , 1976, Steroids.

[21]  W. McGuire,et al.  MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors , 1975, Steroids.

[22]  Gordon Hiroshi Sasaki,et al.  On the mechanism of prolactin and estrogen action in 7,12 dimethylbenz(A)anthracene-induced mammary carcinoma in the rat. II. In vivo tumor responses and estrogen receptor. , 1975, Endocrinology.

[23]  C. Bonne,et al.  Methyltrienolone, a specific ligand for cellular androgen receptors , 1975, Steroids.

[24]  Goral Je,et al.  Comparison of glucocorticoid-binding proteins in normal and neoplastic mammary tissues of the rat. , 1975 .

[25]  J. Thijssen,et al.  Interaction of Δ5-Androstene-3β,17β-diol with Estradiol and Dihydrotestosterone Receptors in Human Myometrial and Mammary Cancer Tissue1 , 1975 .

[26]  J. Wittliff,et al.  Comparison of glucocorticoid-binding proteins in normal and neoplastic mammary tissues of the rat. , 1975, Biochemistry.

[27]  E. Baulieu,et al.  Androgen receptors in the rat ventral prostate and their hormonal control. , 1975, Vitamins and hormones.

[28]  J. Gorski,et al.  Equilibrium binding of estradiol by uterine cell suspensions and whole uteri in vitro. , 1974, Biochemistry.

[29]  P. Kelly,et al.  Prolactin Binding to Rat Mammary Tumor Tissue , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[30]  R. W. Turkington Prolactin receptors in mammary carcinoma cells. , 1974, Cancer research.

[31]  J. Raynaud,et al.  Progesterone binding in the immature rabbit and guinea pig uterus. , 1974, Endocrinology.

[32]  J. Raynaud,et al.  Progesterone binding in the immature mouse and rat uterus. , 1973, Steroids.

[33]  L. Terenius Estrogen and progestogen binders in human and rat mammary carcinoma. , 1973, European journal of cancer.

[34]  W. McGuire Estrogen receptors in human breast cancer. , 1973, The Journal of clinical investigation.

[35]  B. O’Malley,et al.  Progesterone binding in the mouse and rat uterus. , 1972, Endocrinology.

[36]  R. Hahnel,et al.  Estrogen receptors in human breast cancer. 1. Methodology and characterization of receptors. , 1971, Steroids.

[37]  W. McGuire,et al.  Comparison of macromolecular binding of estradiol in hormone-dependent and hormone-independent rat mammary carcinoma. , 1971, Cancer research.

[38]  S. Korenman,et al.  Specific Estrogen Binding by the Cytoplasm of Human Breast Carcinoma , 1970 .

[39]  H. Sutton,et al.  RAPID INDUCTION OF MAMMARY CARCINOMA IN THE RAT AND THE INFLUENCE OF HORMONES ON THE TUMORS , 1959, Journal of Experimental Medicine.

[40]  Clyde Young Kramer,et al.  Extension of multiple range tests to group means with unequal numbers of replications , 1956 .

[41]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[42]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .